Verition Fund Management LLC Eye Point Pharmaceuticals, Inc. Transaction History

Verition Fund Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$7.99 - $15.36 $940,566 - $1.81 Million	-117,718 Reduced 31.24%	259,113 $2.07 Million
Q2 2023 Aug 14, 2023	SELL	$3.03 - $9.0 $335,539 - $996,651	-110,739 Reduced 22.71%	376,831 $3.28 Million
Q1 2023 May 15, 2023	SELL	$2.28 - $5.04 $154,953 - $342,528	-67,962 Reduced 12.23%	487,570 $1.43 Million
Q4 2022 Feb 14, 2023	SELL	$2.37 - $7.2 $21,375 - $64,936	-9,019 Reduced 1.6%	555,532 $1.94 Million
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.12 $187,794 - $300,039	26,982 Added 5.02%	564,551 $4.47 Million
Q2 2022 Aug 15, 2022	BUY	$7.25 - $12.71 $582,544 - $1.02 Million	80,351 Added 17.57%	537,569 $4.23 Million
Q1 2022 May 13, 2022	BUY	$8.67 - $14.11 $1.22 Million - $1.99 Million	141,069 Added 44.62%	457,218 $5.56 Million
Q4 2021 Feb 14, 2022	BUY	$10.18 - $18.4 $3.22 Million - $5.82 Million	316,149 New	316,149 $3.87 Million

151

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $255M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.